why choose us

300×250 Ad Slot

Research Article: Gut microbiome and metabolome to discover pathogenic bacteria and probiotics in ankylosing spondylitis

Date Published: 2024-04-22

Introduction:
Objective: Previous research has partially revealed distinct gut microbiota in ankylosing spondylitis (AS). In this study, we performed non-targeted fecal metabolomics in AS in order to discover the microbiome–metabolome interface in AS. Based on prospective cohort studies, we further explored the impact of the tumor necrosis factor inhibitor (TNFi) on the gut microbiota and metabolites in AS.

Read more

300×250 Ad Slot